Safety & Efficacy of Dual Therapy With Raltegravir/Lamivudine

NCT02284035 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

AIDS

Interventions

DRUG: Raltegravir/3TC
DRUG: EFV/TDF/FTC
DRUG: ATV/r + TDF/FTC or DRV/r + TDF/FTC
DRUG: DTG+ABC/3TC DTG+TDF/FTC EVG/cobi/TDF/FTC RAL+TDF/FTC
DRUG: EFV plus ABC/3TC or RPV/TDF/FTC
DRUG: ATV/r plus ABC/3TC
DRUG: DRV/r + ABC/3TC or LPV/r + ABC/3TC or LPV/r + TDF/FTC
DRUG: RAL plus ABC/3TC
DRUG: Other ART regimens

Sponsor

Juan A. Arnaiz